2024 annual financial data
Cognition Therapeutics 2024 Operating margin
Direct answer
Operating margin was Not calculable.
Operating income was -53,966,000 USD and net income was -33,971,000 USD.
Operating cash flow was -28,474,000 USD.
Get free Cognition Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -53,966,000 USD
- Net income
- -33,971,000 USD
- Operating cash flow
- -28,474,000 USD